Ordinary Adjustment | Solactive US Alzheimer’s & CNS Therapeutics Index | Effective Date 8th January 2026
Solactive US Alzheimer’s & CNS Therapeutics Index:
In the ordinary adjustment, the following composition will be implemented effective open 8th January 2026:
| ACADIA PHARMACEUTICALS INC |
| ALKERMES PLC |
| AVADEL PHARMACEUTICALS PLC |
| AXSOME THERAPEUTICS INC |
| BIOGEN INC |
| CORCEPT THERAPEUTICS INC |
| DENALI THERAPEUTICS INC |
| ELI LILLY & CO |
| HARMONY BIOSCIENCES HOLDINGS INC |
| JAZZ PHARMACEUTICALS PLC |
| NEUROCRINE BIOSCIENCES INC |
| NEW BIOHAVEN |
| PTC THERAPEUTICS INC |
| Praxis Precision Medicines Inc |
| RAPPORT THERAPEUTICS ORD |
| SCHOLAR ROCK HOLDING CORP |
| SUPERNUS PHARMACEUTICALS INC |
| UNIQURE B.V. |
| VERTEX PHARMACEUTICALS INC |
| XENON PHARMACEUTICALS INC |